(Q43640432)

25 November 2017

Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model (English)

1 reference

25 November 2017

0 references

1 reference

M Roqué

1

1 reference

25 November 2017

E D Reis

2

1 reference

25 November 2017

C Cordon-Cardo

3

1 reference

25 November 2017

M B Taubman

4

1 reference

25 November 2017

J T Fallon

5

1 reference

25 November 2017

V Fuster

6

1 reference

25 November 2017

J J Badimon

7

1 reference

25 November 2017

language of work or name

1 reference

1 June 2001

1 reference

25 November 2017

Laboratory Investigation

1 reference

25 November 2017

81

1 reference

25 November 2017

6

1 reference

25 November 2017

895-903

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3780298

25 November 2017

0 references

cites work

Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Migration of smooth muscle and endothelial cells. Critical events in restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Mechanism of action of the immunosuppressant rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Modified Elastic Tissue-Masson Trichrome Stain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Translational control of p27Kip1 accumulation during the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Regulation of chemotaxis by the platelet-derived growth factor receptor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Rapamycin resistance tied to defective regulation of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Rapamycin inhibits vascular smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

Cell cycle progression: new therapeutic target for vascular proliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

Expression of cyclin-dependent kinase inhibitors in vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780298

7 January 2021

10.1038/LABINVEST.3780298

Identifiers

DOI

1 reference

25 November 2017

1 reference